The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Sharples, David Richard
    Director born in April 1955
    Individual (5 offsprings)
    Officer
    2015-11-02 ~ dissolved
    OF - director → CIF 0
    Mr David Richard Sharples
    Born in April 1955
    Individual (5 offsprings)
    Person with significant control
    2017-04-01 ~ dissolved
    PE - Has significant influence or controlCIF 0
  • 2
    Green, Andrew Paul
    Company Director born in January 1965
    Individual (66 offsprings)
    Officer
    2015-11-02 ~ dissolved
    OF - director → CIF 0
    Mr Andrew Paul Green
    Born in January 1965
    Individual (66 offsprings)
    Person with significant control
    2017-04-01 ~ dissolved
    PE - Has significant influence or controlCIF 0
parent relation
Company in focus

PHARMA TECHNOLOGIES LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Debtors
944 GBP2019-12-31
955 GBP2018-12-31
Cash at bank and in hand
403 GBP2019-12-31
176 GBP2018-12-31
Current Assets
1,347 GBP2019-12-31
1,131 GBP2018-12-31
Creditors
Current
-1,200 GBP2019-12-31
-1,200 GBP2018-12-31
Net Current Assets/Liabilities
147 GBP2019-12-31
-69 GBP2018-12-31
Equity
Called up share capital
100 GBP2019-12-31
100 GBP2018-12-31
Retained earnings (accumulated losses)
47 GBP2019-12-31
-169 GBP2018-12-31
Equity
147 GBP2019-12-31
-69 GBP2018-12-31
Amount of corporation tax that is recoverable
Current
844 GBP2019-12-31
855 GBP2018-12-31
Other Debtors
Current
100 GBP2019-12-31
100 GBP2018-12-31
Other Creditors
Current
1,200 GBP2019-12-31
1,200 GBP2018-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2019-12-31
Par Value of Share
Class 1 ordinary share
1 GBP2019-01-01 ~ 2019-12-31
Equity
Called up share capital
100 GBP2019-12-31
100 GBP2018-12-31

  • PHARMA TECHNOLOGIES LIMITED
    Info
    Registered number 09850896
    1st Floor 49 Peter Street, Manchester M2 3NG
    Private Limited Company incorporated on 2015-11-02 and dissolved on 2021-05-04 (5 years 6 months). The company status is Dissolved.
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.